share_log
Breakings ·  Dec 3 06:59
Applied Therapeutics: Following Issuance of a Complete Response Letter by FDA, Received Warning Letter Limited to at-007-1002 Study
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment